Chagas Disease : Synthetic Studies Towards Target Identification and Potential Treatment
Introduction: Chagas disease, caused by Trypanosoma cruzi, remains a significant public health challenge, particularly among socioeconomically disadvantaged populations in developing countries. Although two drugs are currently available, their use is associated to severe side effects, and they are only widely accepted as a treatment against the acute phase of the disease. Background: A Waltherione
